Antineoplastilised ravimid
Contracts total
9 942 679 €
Bids
4
Type
Supplies
Published
02.02.2024
Tender description
Käesoleva hanke eesmärk on sõlmida raamleping antineoplastiliste ravimite ostmiseks HD Lisas 1 toodud nimetuste ja kirjelduste alusel.
Awarded contracts
08.04.2024| Lot | Tenderer | Amount | Bids | Awarded |
|---|---|---|---|---|
| L01AA09 Bendamustin | Apteegikaubanduse Hulgimüük OÜ | 31 028 € | 2 | 05.04.2024 |
| L01AD01 Carmustine | Apteegikaubanduse Hulgimüük OÜ | 116 571 € | 1 | 05.04.2024 |
| L01AB02 Treosulfan | Apteegikaubanduse Hulgimüük OÜ | 308 290 € | 1 | 05.04.2024 |
| L01AB02 Treosulfan | Apteegikaubanduse Hulgimüük OÜ | 36 816 € | 1 | 05.04.2024 |
| L01BA04 Pemetrexed | Apteegikaubanduse Hulgimüük OÜ | 33 925 € | 2 | 05.04.2024 |
| L01CA04 Vinorelbine | OÜ Chirurgicus | 35 100 € | 1 | 02.04.2024 |
| L01CD04 Cabazitaxel | TAMRO EESTI OÜ | 47 132 € | 4 | 05.04.2024 |
| L01FX14 Polatuzumabvedotiin | Roche Eesti Osaühing | 1 019 200 € | 1 | 02.04.2024 |
| L01FX14 Polatuzumabvedotiin | Roche Eesti Osaühing | 54 600 € | 1 | 02.04.2024 |
| L01XD04 Aminolevulinic acid | Apteegikaubanduse Hulgimüük OÜ | 10 296 € | 1 | 05.04.2024 |
| L01XC28 Durvalumab | MAGNUM MEDICAL OÜ | 2 282 838 € | 1 | 05.04.2024 |
| L01FF05 Atesolizumab | Roche Eesti Osaühing | 4 093 804 € | 1 | 02.04.2024 |
| L01FF05 Atesolizumab | Roche Eesti Osaühing | 421 403 € | 1 | 02.04.2024 |
| L01FF05 Atesolizumab | Roche Eesti Osaühing | 1 204 060 € | 1 | 02.04.2024 |
| L01XX24 Pegaspargaas | MAGNUM MEDICAL OÜ | 80 931 € | 1 | 05.04.2024 |
| L02AE03 Goserelin | TAMRO EESTI OÜ | 18 746 € | 2 | 05.04.2024 |
| L02BA03 Fulvestrant | TAMRO EESTI OÜ | 70 298 € | 3 | 05.04.2024 |
| L03AX16 Plerixafor | Apteegikaubanduse Hulgimüük OÜ | 77 641 € | 3 | 05.04.2024 |
Tender lots
24| Lot | Estimated value | Deadline |
|---|---|---|
| L01AA09 Bendamustin | 07.03.2024 | |
| L01AA07 Trofosamid | 07.03.2024 | |
| L01AD01 Carmustine | 07.03.2024 | |
| L01AB02 Treosulfan | 07.03.2024 | |
| L01AB02 Treosulfan | 07.03.2024 | |
| L01BA01 Methotrexat | 07.03.2024 | |
| L01BA04 Pemetrexed | 07.03.2024 | |
| L01CA04 Vinorelbine | 07.03.2024 | |
| L01CA01 Vinblastin | 07.03.2024 | |
| L01CD04 Cabazitaxel | 07.03.2024 | |
| L01DB03 Epirubicin | 07.03.2024 | |
| L01DB06 Idarubicin | 07.03.2024 | |
| L01FX14 Polatuzumabvedotiin | 07.03.2024 | |
| L01FX14 Polatuzumabvedotiin | 07.03.2024 | |
| L01XD04 Aminolevulinic acid | 07.03.2024 | |
| L01XC28 Durvalumab | 07.03.2024 | |
| L01FF05 Atesolizumab | 07.03.2024 | |
| L01FF05 Atesolizumab | 07.03.2024 | |
| L01FF05 Atesolizumab | 07.03.2024 | |
| L01XX23 Mitotan | 07.03.2024 | |
| L01XX24 Pegaspargaas | 07.03.2024 | |
| L02AE03 Goserelin | 07.03.2024 | |
| L02BA03 Fulvestrant | 07.03.2024 | |
| L03AX16 Plerixafor | 07.03.2024 |
Similar open tenders
- Parenteraalsed toitelahusedOpen for bidsDeadline 20.10.2026 tomorrowEstimated value 400 000 €Published 18.09.2026
- KlesrovimabOpen for bidsDeadline 20.10.2026 tomorrowEstimated value 190 000 €Published 05.10.2026
- Puhasruumide desinfektsiooni- ja puhastusvahendidOpen for bidsDeadline 21.10.2026 2 daysPublished 17.09.2026
- Urogenitaalsüsteemi ravimid ja hormoonravimidOpen for bidsDeadline 23.10.2026 4 daysPublished 18.09.2026
- Ravim B01AB05 EnoksapariinOpen for bidsDeadline 27.10.2026 8 daysPublished 21.09.2026
- Kemoteraapias kasutatavad ravimidOpen for bidsDeadline 27.10.2026 8 daysPublished 22.09.2026
Source: Public Procurement Register open data. Amounts exclude VAT. The notice published in the Public Procurement Register is binding.